侧卧位Trendelenburg与半卧位预防呼吸机相关性肺炎的随机多中心试验
本研究为随机、多中心、对照研究,纳入有创机械通气的危重患者,比较侧卧位Trendelenburg(LTP)与半卧位(SRP)对呼吸机相关性肺炎(VAP)发生率的影响。第二次期中分析时因VAP发生率低、次要结局无获益及发生不良事件而提前终止。最终意向性治疗分析纳入LTP组194例和SRP组201例,微生物学确诊VAP发生率LTP组0.5%(1/194) vs SRP组4.0%(8/201),相对风险0.13(95%CI 0.02-1.03,p=0.04)。28天死亡率LTP组30.9%(60/194) vs SRP组26.4%(53/201),相对风险1.17(95%CI 0.86-1.60,p=0.32),其他次要结局无差异。LTP组发生6例严重不良事件(p=0.01 vs SRP)。作者结论认为,鉴于试验提前终止、VAP发生率低及不良事件,研究未能证明显著获益,目前不推荐LTP作为VAP预防措施。
要点
- 在机械通气危重患者中,LTP组微生物学确诊VAP发生率为0.5%(1/194),SRP组为4.0%(8/201),相对风险0.13(95%CI 0.02-1.03,p=0.04)。
- LTP组28天死亡率为30.9%(60/194),SRP组为26.4%(53/201),相对风险1.17(95%CI 0.86-1.60,p=0.32),无显著差异。
- LTP组发生6例严重不良事件,与SRP组相比差异有统计学意义(p=0.01)。
- 试验因VAP发生率低、次要结局无获益及不良事件而在第二次期中分析时提前终止。
- 作者结论认为,目前LTP不能推荐作为VAP的预防措施。
适用人群与场景
- 有创机械通气的危重患者。
研究设计与关键结果
- 研究设计为随机、多中心、对照研究,纳入有创机械通气的危重患者,比较LTP与SRP,共进行两次预计划的期中分析。
- 第二次期中分析时因VAP发生率低、次要结局无获益及发生不良事件而提前终止试验。
- 最终意向性治疗分析纳入LTP组194例、SRP组201例。
- 主要结局微生物学确诊VAP发生率:LTP组0.5%(1/194) vs SRP组4.0%(8/201),相对风险0.13(95%CI 0.02-1.03,p=0.04)。
- 28天死亡率:LTP组30.9%(60/194) vs SRP组26.4%(53/201),相对风险1.17(95%CI 0.86-1.60,p=0.32)。
- 其他次要结局(机械通气时长、ICU住院时长)两组间无差异。
- LTP组发生6例严重不良事件(p=0.01 vs SRP)。
证据类型、等级与局限
- 证据类型:随机、多中心、对照试验。
- 局限:试验提前终止;VAP发生率低;LTP相关不良事件;作者结论明确指出研究未能证明显著获益,并强烈建议进一步临床研究。
对床旁实践的改变
- 作者结论认为,鉴于试验提前终止、VAP发生率低及不良事件,目前LTP不能推荐作为VAP的预防措施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The lateral Trendelenburg position (LTP) may hinder the primary pathophysiologic mechanism of ventilator-associated pneumonia (VAP). We investigated whether placing patients in the LTP would reduce the incidence of VAP in comparison with the semirecumbent position (SRP).
METHODS: This was a randomized, multicenter, controlled study in invasively ventilated critically ill patients. Two preplanned interim analyses were performed. Patients were randomized to be placed in the LTP or the SRP. The primary outcome, assessed by intention-to-treat analysis, was incidence of microbiologically confirmed VAP. Major secondary outcomes included mortality, duration of mechanical ventilation, and intensive care unit length of stay.
RESULTS: At the second interim analysis, the trial was stopped because of low incidence of VAP, lack of benefit in secondary outcomes, and occurrence of adverse events. A total of 194 patients in the LTP group and 201 in the SRP group were included in the final intention-to-treat analysis. The incidence of microbiologically confirmed VAP was 0.5% (1/194) and 4.0% (8/201) in LTP and SRP patients, respectively (relative risk 0.13, 95% CI 0.02-1.03, p = 0.04). The 28-day mortality was 30.9% (60/194) and 26.4% (53/201) in LTP and SRP patients, respectively (relative risk 1.17, 95% CI 0.86-1.60, p = 0.32). Likewise, no differences were found in other secondary outcomes. Six serious adverse events were described in LTP patients (p = 0.01 vs. SRP).
CONCLUSIONS: The LTP slightly decreased the incidence of microbiologically confirmed VAP. Nevertheless, given the early termination of the trial, the low incidence of VAP, and the adverse events associated with the LTP, the study failed to prove any significant benefit. Further clinical investigation is strongly warranted; however, at this time, the LTP cannot be recommended as a VAP preventive measure. CLINICALTRIALS.
GOV IDENTIFIER: NCT01138540.
参考来源
- Li Bassi G, Panigada M, Ranzani OT, et al. Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia. Intensive Care Med. 2017. PMID: 29149418. doi:10.1007/s00134-017-4858-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。